University of Washington-led research, published in 2023, discovered microglia in the brains of people with Alzheimer's ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

November is Alzheimer’s Awareness Month and New York has the second highest rate of Alzheimer’s disease in the U.S. NYC’s ...

Researchers say ‘the Unicorn,’ their invention at the University of Texas Health Science Center, is a game-changer in the ...

Using cerebrospinal fluid from living patients, researchers have identified specific proteins and genetic pathways involved in the development and progression of Alzheimer’s disease.

A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence ...

Biogen’s stock rose 1% Thursday, after Europe’s pharmaceutical regulator issued a positive opinion on the Alzheimer’s disease ...

14, joined together for a common cause: raising money to fund Alzheimer’s Association’s classes and resources for local ...

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

Dementia describes symptoms like memory loss in multiple diseases, and Alzheimer’s is the most common form. Here are the key ...

DOMINICK REUTER/AFP/AFP Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new ...

November is Alzheimer’s Awareness Month. According to the Alzheimer’s Association Mississippi Chapter, nearly 7 million ...